ADVATE 3000UI powder and solvent for solution for injection BAXTER
Active substance: octocog alfa
B02BD02 Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors
Indicated for: bleeding; coagulation disorders
Find medicines for human use by name or active substance.
Browse by initial
461–480 of 2,168 medicines
Active substance: octocog alfa
B02BD02 Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors
Indicated for: bleeding; coagulation disorders
Active substance: octocog alfa
B02BD02 Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors
Indicated for: bleeding; coagulation disorders
Active substance: octocog alfa
B02BD02 Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors
Indicated for: bleeding; coagulation disorders
Active substance: octocog alfa
B02BD02 Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors
Indicated for: bleeding; coagulation disorders
Active substance: ibuprofen
Indicated for: pain and inflammation
Active substance: ibuprofen + pseudoephedrine
R01BA52 Respiratory system | Nasal decongestants for systemic use | Sympathomimetics
Indicated for: pain and inflammation
Active substance: paracetamol + ibuprofen
N02BE51 Nervous system | Other analgesics and antipyretics | Anilides
Indicated for: pain; fever
Active substance: ibuprofen + pseudoephedrine
Indicated for: pain and inflammation
Active substance: ibuprofen
Indicated for: pain and inflammation
Active substance: ibuprofen
Indicated for: pain and inflammation
Active substance: rurioctocog alfa pegol
B02BD02 Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors
Indicated for: bleeding; coagulation disorders
Active substance: rurioctocog alfa pegol
B02BD02 Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors
Indicated for: bleeding; coagulation disorders
Active substance: rurioctocog alfa pegol
B02BD02 Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors
Indicated for: bleeding; coagulation disorders
Active substance: rurioctocog alfa pegol
B02BD02 Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors
Indicated for: bleeding; coagulation disorders
Active substance: rurioctocog alfa pegol
B02BD02 Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors
Indicated for: bleeding; coagulation disorders
Active substance: rurioctocog alfa pegol
B02BD02 Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors
Indicated for: bleeding; coagulation disorders
Active substance: rurioctocog alfa pegol
B02BD02 Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors
Indicated for: bleeding; coagulation disorders
Active substance: rurioctocog alfa pegol
B02BD02 Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors
Indicated for: bleeding; coagulation disorders
Active substance: rADAMTS13
B01AD13 Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Enzymes
Indicated for: congenital thrombotic thrombocytopenic purpura; ADAMTS13 deficiency
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.